Zomedica Corp [ZOM] Records 50-Day SMA of $0.1350
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Zomedica Corp shares valued at $16,500 were purchased by POWERS JOHNNY D on Dec 15 ’23. At $0.17 per share, POWERS JOHNNY D acquired 100,000 shares. The insider’s holdings grew to 1,950 shares worth […]
Taking a Closer Look At Zomedica Corp (ZOM) Following Its Recent Trade
Zomedica Corp’s recent filing unveils that its Director POWERS JOHNNY D acquired Company’s shares for reported $16500.0 on Dec 15 ’23. In the deal valued at $0.17 per share,100,000 shares were bought. As a result of this transaction, POWERS JOHNNY D now holds 1,950 shares worth roughly $273.0. Then, POWERS JOHNNY D bought 100,000 shares, […]
ZOM short interest surges, indicating growing pessimism among investors
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Zomedica Corp shares valued at $16,500 were purchased by POWERS JOHNNY D on Dec 15 ’23. At $0.17 per share, POWERS JOHNNY D acquired 100,000 shares. The insider’s holdings grew to […]
Zomedica Corp [ZOM] Investment Guide: What You Need to Know
Zomedica Corp’s recent filing unveils that its Director POWERS JOHNNY D acquired Company’s shares for reported $16500.0 on Dec 15 ’23. In the deal valued at $0.17 per share,100,000 shares were bought. As a result of this transaction, POWERS JOHNNY D now holds 1,950 shares worth roughly $273.0. Then, POWERS JOHNNY D bought 100,000 shares, […]
Zomedica Corp [ZOM] Shares Fall Approximately -32.83% Over the Year
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Zomedica Corp shares valued at $16,500 were purchased by POWERS JOHNNY D on Dec 15 ’23. At $0.17 per share, POWERS JOHNNY D acquired 100,000 shares. The insider’s holdings grew to […]
ZOM’s latest rating updates from top analysts.
Zomedica Corp’s recent filing unveils that its Director POWERS JOHNNY D acquired Company’s shares for reported $16500.0 on Dec 15 ’23. In the deal valued at $0.17 per share,100,000 shares were bought. As a result of this transaction, POWERS JOHNNY D now holds 1,950 shares worth roughly $292.5. Then, POWERS JOHNNY D bought 100,000 shares, […]
Zomedica Corp (ZOM) receives a Buy rating from Dawson James
Zomedica Corp’s recent filing unveils that its Director POWERS JOHNNY D acquired Company’s shares for reported $16500.0 on Dec 15 ’23. In the deal valued at $0.17 per share,100,000 shares were bought. As a result of this transaction, POWERS JOHNNY D now holds 1,950 shares worth roughly $253.5. Then, POWERS JOHNNY D bought 100,000 shares, […]
Long-Term Outlook Remains Favorable: Zomedica Corp. (ZOM) Stock
The share of the veterinary platform Zomedica Corp. (AMEX: ZOM) climbed 13.86 percent to $0.25 during the trading session on July 6 owing to the completion of the purchase of a promising digital platform. The assets of Revo Squared LLC, which possesses the important MicroView platform for automating medical testing processes for identifying animal illnesses, […]
Zomedica Corp. (ZOM) Stock Prices Climbing as Development of TRUFORMA Continues
Zomedica Corp. (ZOM) stock prices were up by 2.2% as of market close on April 23rd 2021, bringing the price per share up to USD$0.9433. Subsequent pre-market fluctuations saw the stock price climb by 1.45% to USD$0.957. Reduction in Year-Over-Year Net Loss Despite the company having reported a net loss of USD$16.9 million for the […]
Zomedica Pharmaceuticals Corp (ZOM) Announces to Develop Gastrointestinal Testing Panel for TRUFORMA™
In collaboration with Qorvo Biotechnologies, Zomedica Pharmaceuticals Corp plans to develop three new assays for the diagnosis of canine gastrointestinal issues. Zomedica Pharmaceuticals Corp. (ZOM) has surged followed by the announcement of gastrointestinal testing panel for TRUFORMA, which is a point-of-care veterinary diagnostic platform developed by the company. Where most of the market has kicked […]
